iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
July 03, 2018 07:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...